ArticleClinical case reports2026
Coronary Artery Bypass Grafting Under ECPELLA Support After Out-of-Hospital Cardiac Arrest: A Case Report.
Article in Clinical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The survival and social reintegration rate of out-of-hospital cardiac arrest (OHCA) remains extremely low. Venoarterial extracorporeal membrane oxygenation (VA ECMO) is used to support patients with cardiogenic shock. Combining Impella (Abiomed Inc., Danvers, MA, USA) with VA ECMO (ECPELLA) is a promising strategy to stabilize circulation and unload the left ventricle. We report a 46-year-old man who presented in cardiopulmonary arrest due to acute coronary syndrome. Coronary angiography showed multivessel disease, and echocardiography revealed an ejection fraction below 10%. ECPELLA was initiated immediately for hemodynamic stabilization and to promote myocardial recovery. After confirming neurological recovery, emergency coronary artery bypass grafting (CABG) using total arterial grafts and an aorta no-touch strategy was performed under ECPELLA support. The postoperative course was uneventful, and all grafts remained patent. Cardiac function improved, and the patient returned to society 3 months after surgery. ECPELLA enables circulatory stabilization and myocardial recovery in patients with severe cardiogenic shock after cardiac arrest. Combining ECPELLA with total arterial revascularization may achieve excellent neurological and social outcomes, even in cases previously considered unsalvageable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.